GO
Loading...

GSK Fights Back

Wednesday, 23 May 2007 | 2:33 PM ET

Glaxo and the Lancet criticize the findings of American researchers that pushed GSK's stock down about 10 percent this week, with Mike Huckman, CNBC pharmaceuticals reporter